Original Research
Published on 18 Oct 2022
Improved Accuracy of Lymph Node Staging and Long-Term Survival Benefit in Colorectal Cancer With Ex Vivo Arterial Methylene Blue Infiltration
Pathology and Oncology Research
doi 10.3389/pore.2022.1610742
Type at least 3 characters
2,897 articles
Articles
Hypothesis & Theory
Published on 13 Oct 2022
Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610610
Review
Published on 11 Oct 2022
Pulmonary Large Cell Neuroendocrine Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610730
Correction
Published on 06 Oct 2022
Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610658
Original Research
Published on 06 Oct 2022
Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
Pathology and Oncology Research
doi 10.3389/pore.2022.1610537
Hypothesis & Theory
Published on 05 Oct 2022
Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610670
Original Research
Published on 05 Oct 2022
EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits
Pathology and Oncology Research
doi 10.3389/pore.2022.1610607
Original Research
Published on 03 Oct 2022
Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
Pathology and Oncology Research
doi 10.3389/pore.2022.1610645
Review
Published on 23 Sep 2022
On-Target Side Effects of Targeted Therapeutics of Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610694
Hypothesis & Theory
Published on 21 Sep 2022
Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610558
Original Research
Published on 21 Sep 2022
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
Pathology and Oncology Research
doi 10.3389/pore.2022.1610659
Original Research
Published on 20 Sep 2022
Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
Pathology and Oncology Research
doi 10.3389/pore.2022.1610572
Original Research
Published on 16 Sep 2022
Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network
Pathology and Oncology Research
doi 10.3389/pore.2022.1610493
Hypothesis & Theory
Published on 15 Sep 2022
Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes
Pathology and Oncology Research
doi 10.3389/pore.2022.1610641
Case Report
Published on 12 Sep 2022
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
Pathology and Oncology Research
doi 10.3389/pore.2022.1610570
Correction
Published on 08 Sep 2022
Erratum: The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis
Pathology and Oncology Research
doi 10.3389/pore.2022.1610756